HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early biologic behavior of bone grafts. A fine needle aspiration cytology study.

AbstractOBJECTIVE:
To conceptualize, with fine needle aspiration cytology (FNAC), the early cellular events occurring in and around fresh autogenous and allogenic bone grafts during the first 40 postimplantation days.
STUDY DESIGN:
Forty-eight cases of bone grafts were studied by FNAC at serial intervals of 10, 20, 30 and 40 postimplantation days. Twenty patients were recipients of autogenous grafts, 16 received 0.6N HCI partially decalcified allogenic bone implants, and 4 received combined autogenous and allogenic bone grafts (included in the allograft group). There were eight control cases of closed fracture shaft femur, which were managed conservatively.
RESULTS:
The initial cellular responses in autogenous grafts, allografts and controls appear to be a part of the nonspecific reparative process followed by a more specific phase, with a steady increase in relative lymphocyte count from the 20th day onwards. Osteogenesis, as judged by osteoblasts and osteoclasts, was also comparable.
CONCLUSION:
Partially decalcified allografts appear to be a good substitute for autogenous bone grafts in clinical practice when adequate autogenous material is not available. FNAC is a good technique for studying bone graft responses without interfering with graft uptake. It is helpful in the early detection of subclinical infection or any other pathology at the graft site.
AuthorsM Garg, G Dev, K Misra, S M Tuli
JournalActa cytologica (Acta Cytol) Vol. 41 Issue 3 Pg. 765-70 ( 1997) ISSN: 0001-5547 [Print] Switzerland
PMID9167699 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Biopsy, Needle
  • Bone Transplantation (diagnostic imaging, physiology)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Osteogenesis (physiology)
  • Radiography
  • Time Factors
  • Transplantation, Autologous
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: